Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | +3.70% | -8.54% | -87.64% |
01:29pm | Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating | MT |
05-09 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AMYLYX PHARMACEUTICALS, INC. | Biopharmaceuticals | +3.70% | -8.54% | -87.64% | -93.42% | - | 124M |
Technical Rankings Surperformance
- Stock Market
- Equities
- AMLX Stock
- Charts Amylyx Pharmaceuticals, Inc.
- Comparison Chart